Hypertension and survival in chronic hemodialysis patients - Past lessons and future opportunities

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

There is substantial controversy surrounding the benefits of control of hypertension in hemodialysis patients. Unlike the general population, some studies suggest that higher blood pressure in hemodialysis patients offers a survival advantage, what is termed as "reverse epidemiology." To critically analyze the relationship between total and cardiovascular mortality and blood pressure, peer-reviewed, published studies in hemodialysis patients were analyzed. Consideration of the world-wide experience suggests that analysis of incident cohorts reveal a clear link between elevated blood pressure and mortality. Increased pulse pressure, which is primarily due to increased systolic pressure, is also associated with cardiovascular morbidity and mortality. The counterintuitive relationship between blood pressure and mortality appears, in part, to be due to methods of data analysis. When data are analyzed with systolic or diastolic blood pressure as separate models, not conjointly, inverse relationship between blood pressure and total and cardiovascular mortality is generally seen. When both systolic and diastolic blood pressure are considered together, systolic blood pressure or increased pulse pressure assumes a major importance in predicting cardiovascular events whereas diastolic blood pressure retains the inverse relationship. Control of hypertension in hypertensive dialysis patients is associated with improved survival. Furthermore, the use of antihypertensive drug treatment is associated with improved survival regardless of blood pressure control. Low predialysis blood pressure is associated with increased cardiovascular deaths and deaths within 2 years from malignancy or withdrawal from dialysis. These data suggest that hypertension needs to be better controlled in hypertensive hemodialysis patients. Better methods of assessment of blood pressure control, consideration of cardiac structure and function, and performance of randomized controlled trials of pharmacologic and nonpharmacologic strategies are needed to establish benefits and determining goal blood pressure in hemodialysis patients.

Original languageEnglish
Pages (from-to)1-13
Number of pages13
JournalKidney International
Volume67
Issue number1
DOIs
StatePublished - Jan 2005

Fingerprint

Renal Dialysis
Blood Pressure
Hypertension
Survival
Mortality
Dialysis
Hypotension
Antihypertensive Agents
Epidemiology
Cohort Studies

Keywords

  • Cohort studies
  • Hemodialysis
  • Hypertension
  • Survival

ASJC Scopus subject areas

  • Nephrology

Cite this

Hypertension and survival in chronic hemodialysis patients - Past lessons and future opportunities. / Agarwal, Rajiv.

In: Kidney International, Vol. 67, No. 1, 01.2005, p. 1-13.

Research output: Contribution to journalArticle

@article{5a5771bd67e749eaab46c7f856536ead,
title = "Hypertension and survival in chronic hemodialysis patients - Past lessons and future opportunities",
abstract = "There is substantial controversy surrounding the benefits of control of hypertension in hemodialysis patients. Unlike the general population, some studies suggest that higher blood pressure in hemodialysis patients offers a survival advantage, what is termed as {"}reverse epidemiology.{"} To critically analyze the relationship between total and cardiovascular mortality and blood pressure, peer-reviewed, published studies in hemodialysis patients were analyzed. Consideration of the world-wide experience suggests that analysis of incident cohorts reveal a clear link between elevated blood pressure and mortality. Increased pulse pressure, which is primarily due to increased systolic pressure, is also associated with cardiovascular morbidity and mortality. The counterintuitive relationship between blood pressure and mortality appears, in part, to be due to methods of data analysis. When data are analyzed with systolic or diastolic blood pressure as separate models, not conjointly, inverse relationship between blood pressure and total and cardiovascular mortality is generally seen. When both systolic and diastolic blood pressure are considered together, systolic blood pressure or increased pulse pressure assumes a major importance in predicting cardiovascular events whereas diastolic blood pressure retains the inverse relationship. Control of hypertension in hypertensive dialysis patients is associated with improved survival. Furthermore, the use of antihypertensive drug treatment is associated with improved survival regardless of blood pressure control. Low predialysis blood pressure is associated with increased cardiovascular deaths and deaths within 2 years from malignancy or withdrawal from dialysis. These data suggest that hypertension needs to be better controlled in hypertensive hemodialysis patients. Better methods of assessment of blood pressure control, consideration of cardiac structure and function, and performance of randomized controlled trials of pharmacologic and nonpharmacologic strategies are needed to establish benefits and determining goal blood pressure in hemodialysis patients.",
keywords = "Cohort studies, Hemodialysis, Hypertension, Survival",
author = "Rajiv Agarwal",
year = "2005",
month = "1",
doi = "10.1111/j.1523-1755.2005.00050.x",
language = "English",
volume = "67",
pages = "1--13",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Hypertension and survival in chronic hemodialysis patients - Past lessons and future opportunities

AU - Agarwal, Rajiv

PY - 2005/1

Y1 - 2005/1

N2 - There is substantial controversy surrounding the benefits of control of hypertension in hemodialysis patients. Unlike the general population, some studies suggest that higher blood pressure in hemodialysis patients offers a survival advantage, what is termed as "reverse epidemiology." To critically analyze the relationship between total and cardiovascular mortality and blood pressure, peer-reviewed, published studies in hemodialysis patients were analyzed. Consideration of the world-wide experience suggests that analysis of incident cohorts reveal a clear link between elevated blood pressure and mortality. Increased pulse pressure, which is primarily due to increased systolic pressure, is also associated with cardiovascular morbidity and mortality. The counterintuitive relationship between blood pressure and mortality appears, in part, to be due to methods of data analysis. When data are analyzed with systolic or diastolic blood pressure as separate models, not conjointly, inverse relationship between blood pressure and total and cardiovascular mortality is generally seen. When both systolic and diastolic blood pressure are considered together, systolic blood pressure or increased pulse pressure assumes a major importance in predicting cardiovascular events whereas diastolic blood pressure retains the inverse relationship. Control of hypertension in hypertensive dialysis patients is associated with improved survival. Furthermore, the use of antihypertensive drug treatment is associated with improved survival regardless of blood pressure control. Low predialysis blood pressure is associated with increased cardiovascular deaths and deaths within 2 years from malignancy or withdrawal from dialysis. These data suggest that hypertension needs to be better controlled in hypertensive hemodialysis patients. Better methods of assessment of blood pressure control, consideration of cardiac structure and function, and performance of randomized controlled trials of pharmacologic and nonpharmacologic strategies are needed to establish benefits and determining goal blood pressure in hemodialysis patients.

AB - There is substantial controversy surrounding the benefits of control of hypertension in hemodialysis patients. Unlike the general population, some studies suggest that higher blood pressure in hemodialysis patients offers a survival advantage, what is termed as "reverse epidemiology." To critically analyze the relationship between total and cardiovascular mortality and blood pressure, peer-reviewed, published studies in hemodialysis patients were analyzed. Consideration of the world-wide experience suggests that analysis of incident cohorts reveal a clear link between elevated blood pressure and mortality. Increased pulse pressure, which is primarily due to increased systolic pressure, is also associated with cardiovascular morbidity and mortality. The counterintuitive relationship between blood pressure and mortality appears, in part, to be due to methods of data analysis. When data are analyzed with systolic or diastolic blood pressure as separate models, not conjointly, inverse relationship between blood pressure and total and cardiovascular mortality is generally seen. When both systolic and diastolic blood pressure are considered together, systolic blood pressure or increased pulse pressure assumes a major importance in predicting cardiovascular events whereas diastolic blood pressure retains the inverse relationship. Control of hypertension in hypertensive dialysis patients is associated with improved survival. Furthermore, the use of antihypertensive drug treatment is associated with improved survival regardless of blood pressure control. Low predialysis blood pressure is associated with increased cardiovascular deaths and deaths within 2 years from malignancy or withdrawal from dialysis. These data suggest that hypertension needs to be better controlled in hypertensive hemodialysis patients. Better methods of assessment of blood pressure control, consideration of cardiac structure and function, and performance of randomized controlled trials of pharmacologic and nonpharmacologic strategies are needed to establish benefits and determining goal blood pressure in hemodialysis patients.

KW - Cohort studies

KW - Hemodialysis

KW - Hypertension

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=10944220189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10944220189&partnerID=8YFLogxK

U2 - 10.1111/j.1523-1755.2005.00050.x

DO - 10.1111/j.1523-1755.2005.00050.x

M3 - Article

C2 - 15610223

AN - SCOPUS:10944220189

VL - 67

SP - 1

EP - 13

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 1

ER -